4th Heidelberg Conference Neural Therapy 2018
June 21st – 23rd 2018
Therapy with Local Anesthetics
Meeting place for students, doctors, scientists
Main Topic 2018:
“Neural Therapy and Chronic Inflammation”
Invitation
The academic level, the exchange between speakers, physicians and students and the lovely Heidelberg summer, have all been appreciated by our participants since 2014. From research directly put into practice – International experts from selected experts from the basic sciences, hospitals and practices will present their recent findings. Particular emphasis will be given to direct implementation in your everyday practice. The “Basic Certificate for Neural Therapy” from University Heidelberg, in conjunction with DGfAN e.V., can be acquired at the congress. Further information under the page Examination Course.
We’re looking forward to seeing you in Heidelberg in June 2018!
Dr. Stefan Weinschenk & Prof. Dr. Hubert Bardenheuer
“I am very satisfied and have gained a lot of new insights and above all experiences from the speakers and also participants.”
Sarah M. from Heidelberg
“At the conference with colleagues, we were able to discuss questions that we gathered over the year, and decisions that had to be made. This event is the best place to deal with all topics in and around the field of neural therapy- to learn and share.”
Hermann S. from Heidelberg
Greeting from Prof. Dr. Dr. h.c. Manfred Zimmermann
Professor of Physiology, University of Heidelberg
Dear Participants,
Neural therapy was born more than 100 years ago from the observation that short-acting local anesthetics often bring about long-term analgesia. This is frequently accompanied by anti-inflammatory and other curative effects. Despite the fact that it is widely practiced, neural therapy remains a controversial topic. To this day there is no standardized documentation of the results of neural therapy, and no modern scientific substantiation for the complex interaction between the neural immune systems.
Local anesthetics have a wide range of molecular effects: In addition to stimulus transmission, it also inhibits the release of proinflammatory neuropeptides from sensory nerves, acts on endocannabinoid receptors, and much more. The latest findings will be presented at the lecture on Friday.
The Heidelberger HUNTER Group seeks to advance these findings and set new standards in their application and interpretation. I welcome you to the fifth Heidelberg Conference Neural Therapy 2018 and hope you attain many new insights and skills for your medical routine.
Prof. Dr. Manfred Zimmermann
Honorary Chairman of the HUNTER-Group